MiR-429 regulates the transition between Hypoxia-Inducible Factor (HIF)1A and HIF3A expression in human endothelial cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Janaszak Jasiecka, Anna ^a   Bartoszewska, Sylwia ^a   Kochan, Kinga ^a   Piotrowski, Arkadiusz ^a   Kalinowski, Leszek ^a   Kamysz, Wojciech ^a   Ochocka, Renata J ^a   Bartoszewski, Rafał ^a   Collawn, James F ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HIF1A PROTEIN, HUMAN; HIF3A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; MIRN429 MICRORNA, HUMAN;

BIOSYNTHESIS; CELL CULTURE; CELL HYPOXIA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; UMBILICAL VEIN ENDOTHELIAL CELL;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL HYPOXIA; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICRORNAS;

EID: 84960421770     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22775     Document Type: Article

References (43)

1. Hausenloy, D. J. & Yellon, D. M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. The Journal of clinical investigation 123, 92-100, doi: 10.1172/JCI62874 (2013).
2. Semenza, G. L. Perspectives on oxygen sensing. Cell 98, 281-284 (1999).
3. Semenza, G. L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annual review of cell and developmental biology 15, 551-578, doi: 10.1146/annurev.cellbio.15.1.551 (1999).
4. Majmundar, A. J., Wong, W. J. & Simon, M. C. Hypoxia-inducible factors and the response to hypoxic stress. Molecular cell 40, 294-309, doi: 10.1016/j.molcel.2010.09.022 (2010).
5. Wang, G. L. & Semenza, G. L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proceedings of the National Academy of Sciences of the United States of America 90, 4304-4308 (1993).
6. Kaelin, W. G., Jr. & Ratcliffe, P. J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Molecular cell 30, 393-402, doi: 10.1016/j.molcel.2008.04.009 (2008).
7. Gu, Y. Z., Moran, S. M., Hogenesch, J. B., Wartman, L. & Bradfield, C. A. Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. Gene expression 7, 205-213 (1998).
8. Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275, doi: 10.1038/20459 (1999).
9. Koh, M. Y. & Powis, G. Passing the baton: the HIF switch. Trends Biochem Sci 37, 364-372, doi: 10.1016/j.tibs.2012.06.004 (2012).
10. Bartoszewska, S. et al. The hypoxia-inducible miR-429 regulates hypoxia-inducible factor-1alpha expression in human endothelial cells through a negative feedback loop. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 29, 1467-1479, doi: 10.1096/fj.14-267054 (2015).
11. Maynard, M. A. et al. Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. The Journal of biological chemistry 278, 11032-11040, doi: 10.1074/jbc.M208681200 (2003).
12. Heikkila, M., Pasanen, A., Kivirikko, K. I. & Myllyharju, J. Roles of the human hypoxia-inducible factor (HIF)-3alpha variants in the hypoxia response. Cellular and molecular life sciences : CMLS 68, 3885-3901, doi: 10.1007/s00018-011-0679-5 (2011).
13. Pasanen, A. et al. Hypoxia-inducible factor (HIF)-3alpha is subject to extensive alternative splicing in human tissues and cancer cells and is regulated by HIF-1 but not HIF-2. The international journal of biochemistry & cell biology 42, 1189-1200, doi: 10.1016/j. biocel.2010.04.008 (2010).
14. Ando, H. et al. A hypoxia-inducible factor (HIF)-3alpha splicing variant, HIF-3alpha4 impairs angiogenesis in hypervascular malignant meningiomas with epigenetically silenced HIF-3alpha4. Biochemical and biophysical research communications 433, 139-144, doi: 10.1016/j.bbrc.2013.02.044 (2013).
15. Maynard, M. A. et al. Human HIF-3alpha4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 19, 1396-1406, doi: 10.1096/fj.05-3788com (2005).
16. Zhang, P. et al. Hypoxia-inducible factor 3 is an oxygen-dependent transcription activator and regulates a distinct transcriptional response to hypoxia. Cell reports 6, 1110-1121, doi: 10.1016/j.celrep.2014.02.011 (2014).
17. Li, Q. F., Wang, X. R., Yang, Y. W. & Lin, H. Hypoxia upregulates hypoxia inducible factor (HIF)-3alpha expression in lung epithelial cells: characterization and comparison with HIF-1alpha. Cell research 16, 548-558, doi: 10.1038/sj.cr.7310072 (2006).
18. Madanecki, P. et al. Regulation of angiogenesis by hypoxia: the role of microRNA. Cellular & molecular biology letters 18, 47-57, doi: 10.2478/s11658-012-0037-0 (2013).
19. Greco, S. & Martelli, F. MicroRNAs in Hypoxia Response. Antioxid Redox Signal 21, 1164-1166, doi: 10.1089/ars.2014.6083 (2014).
20. Greco, S., Gaetano, C. & Martelli, F. HypoxamiR regulation and function in ischemic cardiovascular diseases. Antioxidants & redox signaling 21, 1202-1219, doi: 10.1089/ars.2013.5403 (2014).
21. Gits, C. M. et al. MicroRNA response to hypoxic stress in soft tissue sarcoma cells: microRNA mediated regulation of HIF3alpha. BMC Cancer 14, 429, doi: 10.1186/1471-2407-14-429 (2014).
22. Kruger, J. & Rehmsmeier, M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 34, W451-454, doi: 10.1093/nar/gkl243 (2006).
23. Staton, A. A. & Giraldez, A. J. Use of target protector morpholinos to analyze the physiological roles of specific miRNA-mRNA pairs in vivo. Nature protocols 6, 2035-2049, doi: 10.1038/nprot.2011.423 (2011).
24. Schneider, A., Younis, R. H. & Gutkind, J. S. Hypoxia-induced energy stress inhibits the mTOR pathway by activating an AMPK/REDD1 signaling axis in head and neck squamous cell carcinoma. Neoplasia 10, 1295-1302 (2008).
25. Schwarzer, R. et al. REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase. Oncogene 24, 1138-1149, doi: 10.1038/sj.onc.1208236 (2005).
26. Brugarolas, J. et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 18, 2893-2904, doi: 10.1101/gad.1256804 (2004).
27. 2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Annals of the New York Academy of Sciences 973, 443-447 (2002).
28. Veschini, L. et al. Hypoxia-inducible transcription factor-1 alpha determines sensitivity of endothelial cells to the proteosome inhibitor bortezomib. Blood 109, 2565-2570, doi: 10.1182/blood-2006-06-032664 (2007).
29. Rapisarda, A. et al. Schedule-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts. Cancer research 64, 6845-6848, doi: 10.1158/0008-5472.CAN-04-2116 (2004).
30. Koury, M. J. & Haase, V. H. Anaemia in kidney disease: harnessing hypoxia responses for therapy. Nature reviews. Nephrology 11, 394-410, doi: 10.1038/nrneph.2015.82 (2015).
31. Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111, doi: 10.1093/bioinformatics/btp120 (2009).
32. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nature biotechnology 28, 511-515, doi: 10.1038/nbt.1621 (2010).
33. Bartoszewski, R. et al. CFTR expression regulation by the unfolded protein response. Methods in enzymology 491, 3-24, doi: 10.1016/B978-0-12-385928-0.00001-8 (2011).
34. Bartoszewski, R. et al. Mangiferin has an additive effect on the apoptotic properties of hesperidin in Cyclopia sp. tea extracts. PloS one 9, e92128, doi: 10.1371/journal.pone.0092128 (2014).
35. Bartoszewski, R. et al. The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes. The Journal of biological chemistry 286, 41862-41870, doi: 10.1074/jbc.M111.304956 (2011).
36. Larionov, A., Krause, A. & Miller, W. A standard curve based method for relative real time PCR data processing. BMC Bioinformatics 6, 62, doi: 10.1186/1471-2105-6-62 (2005).
37. Bakhashab, S. et al. Reference Genes for Expression Studies in Hypoxia and Hyperglycemia Models in Human Umbilical Vein Endothelial Cells. G3: Genes|Genomes|Genetics 4, 2159-2165, doi: 10.1534/g3.114.013102 (2014).
38. Østergaard, L. et al. Proteomics reveals lowering oxygen alters cytoskeletal and endoplasmatic stress proteins in human endothelial cells. PROTEOMICS 9, 4457-4467, doi: 10.1002/pmic.200800130 (2009).
39. Yang, Y. et al. Effects of hypoxia on mRNA expression of housekeeping genes in rat brain tissue and primary cultured neural cells. Front. Med. China 2, 239-243, doi: 10.1007/s11684-008-0045-7 (2008).
40. Zhong, H. & Simons, J. W. Direct Comparison of GAPDH, β -Actin, Cyclophilin, and 28S rRNA as Internal Standards for Quantifying RNA Levels under Hypoxia. Biochemical and Biophysical Research Communications 259, 523-526, doi: http://dx.doi.org/10.1006/bbrc.1999.0815 (1999).
41. Liu, L. et al. Hypoxia-Induced Energy Stress Regulates mRNA Translation and Cell Growth. Molecular Cell 21, 521-531, doi: http://dx.doi.org/10.1016/j.molcel.2006.01.010 (2006).
42. Fähling, M. Surviving hypoxia by modulation of mRNA translation rate. Journal of Cellular and Molecular Medicine 13, 2770-2779, doi: 10.1111/j.1582-4934.2009.00875.x (2009).
43. Derrick, T. R., Bates, B. T. & Dufek, J. S. Evaluation of time-series data sets using the Pearson product-moment correlation coefficient. Medicine and science in sports and exercise 26, 919-928 (1994).